Nanotrap® Particles have been demonstrated to capture and concentrate the following respiratory viruses: influenza A H1N1(1), Influenza A H3N2(1), influenza B(1), respiratory syncytial virus A2001/3-12 strain(1), coronavirus strain 229E(1), and coronavirus strain OC43(2).
Compatible with multiple nucleic acid extraction kits.
Ceres Nanosciences is currently evaluating whether Nanotrap® Virus Particles can capture and concentrate SARS-CoV-2.
If you have an idea for a collaboration using the Nanotrap® Virus Capture Kit in your COVID-19 project, please contact COVID19@ceresnano.com.
The Nanotrap® Virus Capture Kit improves the performance of your downstream analytical methods (e.g., PCR, Western blot, NGS, protein assays, infectivity assays) by concentrating whole virus from large volumes (3 mL) of complex biological fluids into a significantly smaller volume (less than 100 µL).